INVESTOR ALERT: Investigation of CorMedix Inc. (CRMD) Announced by Holzer & Holzer, LLC

Core Insights - CorMedix Inc. is under investigation by Holzer & Holzer, LLC for potential non-compliance with federal securities laws following the announcement of its fourth quarter and full year 2024 financial results [1] - The company anticipates net price erosion starting in the second quarter of 2025, which has negatively impacted its stock price [1] Financial Performance - CorMedix reported its fourth quarter and full year 2024 financial results on March 25, 2025 [1] - The earnings call indicated expectations of net price erosion beginning in Q2 2025 [1] Legal Context - Holzer & Holzer, LLC is a law firm specializing in securities litigation and has a history of representing shareholders in cases of corporate misconduct [3] - The firm has recovered hundreds of millions of dollars for shareholders since its founding in 2000 [3]